formamidine has been researched along with Cancer of Ovary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denel-Bobrowska, M; Lukawska, M; Marczak, A; Oszczapowicz, I | 1 |
1 other study(ies) available for formamidine and Cancer of Ovary
Article | Year |
---|---|
Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines.
Topics: Adenocarcinoma, Clear Cell; Amidines; Antibiotics, Antineoplastic; Apoptosis; Caspases; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Ovarian Neoplasms; Tumor Cells, Cultured | 2016 |